Big companies are looking to blockchain technology to track transactions, finds Andy Extance, while upstarts exploit its cryptocurrency origins
Despite growing realism over the hype surrounding bitcoin, transaction-recording technology similar to that powering the digital currency may rescue the pharmaceutical industry from a new predicament. The issue arises from the 2013 US Drug Supply Chain Security Act (DSCSA), which mandates individual drug pack tracking to fight counterfeiting.